Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice

To unveil the pathological changes associated with demyelination in schizophrenia (SZ) and its consequential impact on interstitial fluid (ISF) drainage, and to investigate the therapeutic efficacy of ursolic acid (UA) in treating demyelination and the ensuing abnormalities in ISF drainage in SZ. Fe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Beijing da xue xue bao. Journal of Peking University. Yi xue ban 2024-06, Vol.56 (3), p.487
Hauptverfasser: Long, Ren, Mao, Xin, Gao, Tianzi, Xie, Qian, Tan, Hanbo, Li, Ziyin, Han, Hongbin, Yuan, Lan
Format: Artikel
Sprache:chi
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 487
container_title Beijing da xue xue bao. Journal of Peking University. Yi xue ban
container_volume 56
creator Long, Ren
Mao, Xin
Gao, Tianzi
Xie, Qian
Tan, Hanbo
Li, Ziyin
Han, Hongbin
Yuan, Lan
description To unveil the pathological changes associated with demyelination in schizophrenia (SZ) and its consequential impact on interstitial fluid (ISF) drainage, and to investigate the therapeutic efficacy of ursolic acid (UA) in treating demyelination and the ensuing abnormalities in ISF drainage in SZ. Female C57BL/6J mice, aged 6-8 weeks and weighing (20±2) g, were randomly divided into three groups: control, SZ model, and UA treatment. The control group received intraperitoneal injection (ip) of physiological saline and intragastric administration (ig) of 1% carboxymethylcellulose sodium (CMC-Na). The SZ model group was subjected to ip injection of 2 mg/kg dizocilpine maleate (MK-801) and ig administration of 1% CMC-Na. The UA treatment group underwent ig administration of 25 mg/kg UA and ip injection of 2 mg/kg MK-801. The treatment group received UA pretreatment via ig administration for one week, followed by a two-week drug intervention for all the three groups. Behavioral assessments, including the open field
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3068754755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3068754755</sourcerecordid><originalsourceid>FETCH-LOGICAL-p565-f07ca91b3fd2244c9477a9bb4867784ea23f24bc007b63234ed32a44cc2a92f83</originalsourceid><addsrcrecordid>eNo10MtqwzAQBVAvWpqQ5heKlt0E9LJlL0voCwLdpNCdGUnjZkB-VLIL6ddX0HQzs7iHCzNXxVpURuzy-FgV25TIci4EV41QN8VK1XWlhSrXhXuPaQzkGDjyjPopjt_omcf-jIEGmGkcGAw5GmaMaaaZILAuLFn7CFl8IvOUxuhznBVL7kQ_43SKOBCwnhzeFtcdhITby94Ux6fH4_5ld3h7ft0_HHZTWZW7jhsHjbCq81Jq7RptDDTW6royptYIUnVSW8e5sZWSSqNXEjJ0EhrZ1WpT3P_V5hu-Fkxz21NyGAIMOC6pVbyqTalNWWZ6d6GL7dG3U6Qe4rn9_4v6BQhkYF0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3068754755</pqid></control><display><type>article</type><title>Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice</title><source>PubMed Central (Open Access)</source><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Long, Ren ; Mao, Xin ; Gao, Tianzi ; Xie, Qian ; Tan, Hanbo ; Li, Ziyin ; Han, Hongbin ; Yuan, Lan</creator><creatorcontrib>Long, Ren ; Mao, Xin ; Gao, Tianzi ; Xie, Qian ; Tan, Hanbo ; Li, Ziyin ; Han, Hongbin ; Yuan, Lan</creatorcontrib><description>To unveil the pathological changes associated with demyelination in schizophrenia (SZ) and its consequential impact on interstitial fluid (ISF) drainage, and to investigate the therapeutic efficacy of ursolic acid (UA) in treating demyelination and the ensuing abnormalities in ISF drainage in SZ. Female C57BL/6J mice, aged 6-8 weeks and weighing (20±2) g, were randomly divided into three groups: control, SZ model, and UA treatment. The control group received intraperitoneal injection (ip) of physiological saline and intragastric administration (ig) of 1% carboxymethylcellulose sodium (CMC-Na). The SZ model group was subjected to ip injection of 2 mg/kg dizocilpine maleate (MK-801) and ig administration of 1% CMC-Na. The UA treatment group underwent ig administration of 25 mg/kg UA and ip injection of 2 mg/kg MK-801. The treatment group received UA pretreatment via ig administration for one week, followed by a two-week drug intervention for all the three groups. Behavioral assessments, including the open field</description><identifier>ISSN: 1671-167X</identifier><identifier>PMID: 38864135</identifier><language>chi</language><publisher>China</publisher><subject>Animals ; Aquaporin 4 - metabolism ; Demyelinating Diseases - drug therapy ; Disease Models, Animal ; Dizocilpine Maleate ; Extracellular Fluid - drug effects ; Extracellular Fluid - metabolism ; Female ; Mice ; Mice, Inbred C57BL ; Schizophrenia - drug therapy ; Triterpenes - pharmacology ; Triterpenes - therapeutic use ; Ursolic Acid</subject><ispartof>Beijing da xue xue bao. Journal of Peking University. Yi xue ban, 2024-06, Vol.56 (3), p.487</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38864135$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Long, Ren</creatorcontrib><creatorcontrib>Mao, Xin</creatorcontrib><creatorcontrib>Gao, Tianzi</creatorcontrib><creatorcontrib>Xie, Qian</creatorcontrib><creatorcontrib>Tan, Hanbo</creatorcontrib><creatorcontrib>Li, Ziyin</creatorcontrib><creatorcontrib>Han, Hongbin</creatorcontrib><creatorcontrib>Yuan, Lan</creatorcontrib><title>Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice</title><title>Beijing da xue xue bao. Journal of Peking University. Yi xue ban</title><addtitle>Beijing Da Xue Xue Bao Yi Xue Ban</addtitle><description>To unveil the pathological changes associated with demyelination in schizophrenia (SZ) and its consequential impact on interstitial fluid (ISF) drainage, and to investigate the therapeutic efficacy of ursolic acid (UA) in treating demyelination and the ensuing abnormalities in ISF drainage in SZ. Female C57BL/6J mice, aged 6-8 weeks and weighing (20±2) g, were randomly divided into three groups: control, SZ model, and UA treatment. The control group received intraperitoneal injection (ip) of physiological saline and intragastric administration (ig) of 1% carboxymethylcellulose sodium (CMC-Na). The SZ model group was subjected to ip injection of 2 mg/kg dizocilpine maleate (MK-801) and ig administration of 1% CMC-Na. The UA treatment group underwent ig administration of 25 mg/kg UA and ip injection of 2 mg/kg MK-801. The treatment group received UA pretreatment via ig administration for one week, followed by a two-week drug intervention for all the three groups. Behavioral assessments, including the open field</description><subject>Animals</subject><subject>Aquaporin 4 - metabolism</subject><subject>Demyelinating Diseases - drug therapy</subject><subject>Disease Models, Animal</subject><subject>Dizocilpine Maleate</subject><subject>Extracellular Fluid - drug effects</subject><subject>Extracellular Fluid - metabolism</subject><subject>Female</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Schizophrenia - drug therapy</subject><subject>Triterpenes - pharmacology</subject><subject>Triterpenes - therapeutic use</subject><subject>Ursolic Acid</subject><issn>1671-167X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo10MtqwzAQBVAvWpqQ5heKlt0E9LJlL0voCwLdpNCdGUnjZkB-VLIL6ddX0HQzs7iHCzNXxVpURuzy-FgV25TIci4EV41QN8VK1XWlhSrXhXuPaQzkGDjyjPopjt_omcf-jIEGmGkcGAw5GmaMaaaZILAuLFn7CFl8IvOUxuhznBVL7kQ_43SKOBCwnhzeFtcdhITby94Ux6fH4_5ld3h7ft0_HHZTWZW7jhsHjbCq81Jq7RptDDTW6royptYIUnVSW8e5sZWSSqNXEjJ0EhrZ1WpT3P_V5hu-Fkxz21NyGAIMOC6pVbyqTalNWWZ6d6GL7dG3U6Qe4rn9_4v6BQhkYF0</recordid><startdate>20240618</startdate><enddate>20240618</enddate><creator>Long, Ren</creator><creator>Mao, Xin</creator><creator>Gao, Tianzi</creator><creator>Xie, Qian</creator><creator>Tan, Hanbo</creator><creator>Li, Ziyin</creator><creator>Han, Hongbin</creator><creator>Yuan, Lan</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20240618</creationdate><title>Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice</title><author>Long, Ren ; Mao, Xin ; Gao, Tianzi ; Xie, Qian ; Tan, Hanbo ; Li, Ziyin ; Han, Hongbin ; Yuan, Lan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p565-f07ca91b3fd2244c9477a9bb4867784ea23f24bc007b63234ed32a44cc2a92f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Aquaporin 4 - metabolism</topic><topic>Demyelinating Diseases - drug therapy</topic><topic>Disease Models, Animal</topic><topic>Dizocilpine Maleate</topic><topic>Extracellular Fluid - drug effects</topic><topic>Extracellular Fluid - metabolism</topic><topic>Female</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Schizophrenia - drug therapy</topic><topic>Triterpenes - pharmacology</topic><topic>Triterpenes - therapeutic use</topic><topic>Ursolic Acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Long, Ren</creatorcontrib><creatorcontrib>Mao, Xin</creatorcontrib><creatorcontrib>Gao, Tianzi</creatorcontrib><creatorcontrib>Xie, Qian</creatorcontrib><creatorcontrib>Tan, Hanbo</creatorcontrib><creatorcontrib>Li, Ziyin</creatorcontrib><creatorcontrib>Han, Hongbin</creatorcontrib><creatorcontrib>Yuan, Lan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Beijing da xue xue bao. Journal of Peking University. Yi xue ban</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Long, Ren</au><au>Mao, Xin</au><au>Gao, Tianzi</au><au>Xie, Qian</au><au>Tan, Hanbo</au><au>Li, Ziyin</au><au>Han, Hongbin</au><au>Yuan, Lan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice</atitle><jtitle>Beijing da xue xue bao. Journal of Peking University. Yi xue ban</jtitle><addtitle>Beijing Da Xue Xue Bao Yi Xue Ban</addtitle><date>2024-06-18</date><risdate>2024</risdate><volume>56</volume><issue>3</issue><spage>487</spage><pages>487-</pages><issn>1671-167X</issn><abstract>To unveil the pathological changes associated with demyelination in schizophrenia (SZ) and its consequential impact on interstitial fluid (ISF) drainage, and to investigate the therapeutic efficacy of ursolic acid (UA) in treating demyelination and the ensuing abnormalities in ISF drainage in SZ. Female C57BL/6J mice, aged 6-8 weeks and weighing (20±2) g, were randomly divided into three groups: control, SZ model, and UA treatment. The control group received intraperitoneal injection (ip) of physiological saline and intragastric administration (ig) of 1% carboxymethylcellulose sodium (CMC-Na). The SZ model group was subjected to ip injection of 2 mg/kg dizocilpine maleate (MK-801) and ig administration of 1% CMC-Na. The UA treatment group underwent ig administration of 25 mg/kg UA and ip injection of 2 mg/kg MK-801. The treatment group received UA pretreatment via ig administration for one week, followed by a two-week drug intervention for all the three groups. Behavioral assessments, including the open field</abstract><cop>China</cop><pmid>38864135</pmid></addata></record>
fulltext fulltext
identifier ISSN: 1671-167X
ispartof Beijing da xue xue bao. Journal of Peking University. Yi xue ban, 2024-06, Vol.56 (3), p.487
issn 1671-167X
language chi
recordid cdi_proquest_miscellaneous_3068754755
source PubMed Central (Open Access); MEDLINE; EZB Electronic Journals Library
subjects Animals
Aquaporin 4 - metabolism
Demyelinating Diseases - drug therapy
Disease Models, Animal
Dizocilpine Maleate
Extracellular Fluid - drug effects
Extracellular Fluid - metabolism
Female
Mice
Mice, Inbred C57BL
Schizophrenia - drug therapy
Triterpenes - pharmacology
Triterpenes - therapeutic use
Ursolic Acid
title Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A53%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ursolic%20acid%20improved%20demyelination%20and%20interstitial%20fluid%20drainage%20disorders%20in%20schizophrenia%20mice&rft.jtitle=Beijing%20da%20xue%20xue%20bao.%20Journal%20of%20Peking%20University.%20Yi%20xue%20ban&rft.au=Long,%20Ren&rft.date=2024-06-18&rft.volume=56&rft.issue=3&rft.spage=487&rft.pages=487-&rft.issn=1671-167X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E3068754755%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3068754755&rft_id=info:pmid/38864135&rfr_iscdi=true